Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

British Journal of Cancer

Volumn 96, Issue 7, 2007, Pages 1037-1042

  Welsh, F K S ^a   Tilney, H S ^b   Tekkis, P P ^b   John, T G ^a   Rees, M ^a  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Colorectal metastases; Liver resection; Neoadjuvant chemotherapy

Indexed keywords

5 FLUOROURACIL PLUS FOLINIC ACID; ANTINEOPLASTIC AGENT; CAPECITABINE; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; UNCLASSIFIED DRUG;

ABSCESS; ADJUVANT CHEMOTHERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BILE LEAKAGE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HEART ARREST; HEART DISEASE; HUMAN; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE ORGAN FAILURE; OPERATION DURATION; PERITONITIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REOPERATION; RESPIRATORY TRACT DISEASE; SEPSIS; SURGICAL RISK; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; WOUND INFECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSTOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247262529     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603670     Document Type: Article

References (35)

1. Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D, Kunstlinger F, Levi F, Bismuth F (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8: 347-353
2. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238: 871-883
3. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240: 1052-1061, discussion 1061-4.
4. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y (2003) Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7: 109-115, discussion 116 -117.
5. Basu S, Rees M, Tamijmaran A, Bygrave S, John TJ (2003) Influence of preoperative chemotherapy on recovery after hepatic resection for colorectal liver metastases. Br J Surg 90: 372
6. Basu S, Tamijmarane A, Bulters D, Wells JKG, John TG, Rees M (2004) An alternative method of wound pain control following hepatic resection: a preliminary study. HPB 6: 186-189
7. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O (2000) Seven hundred and forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191: 38- 46
8. Benoist S, Brouquet A, Penna C, Catherine J, El Hajjam M, Chagnon S, Mitry E, Rougier P, Nordlinger B (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24: 3939- 3945
9. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224: 509-520
10. Cancer Research UK (2006) http://info.cancerresearchuk.org/cancerstats/ types/bowel/?a=544 (last accessed 2/10/2006)
11. Didolkar MS, Fitzpatrick JL, Elias EG, Whitley N, Keramati B, Suter CM, Brown S (1989) Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 169: 17-26
12. Elias D, Lasser P, Rougier P, Ducreux M, Bognel C, Roche A (1995) Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 180: 213- 219
13. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200: 845- 853
14. Fong Y, Bentrem DJ (2006) CASH (Chemotherapy-Associated Steatohepatitis) costs. Ann Surg 243: 8-9
15. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318, (discussion 318-321)
16. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, Primrose JN, Parks RW (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55(S3): iii1-iii8
17. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D, Sugarbaker PH, Iwatsuki S, Starzl T, Ramming KP, Longmire WP, Otoole K, Petrelli NJ, Herrera L, Cady B, McDermott W, Nims T, Enker WE, Coppa GF, Blumgart LH, Bradpiece H, Urist M, Aldrete JS, Schlag P, Hohenberger P, Steele G, Hodgson WJ, Hardy TG, Harbora D, McPherson TA, Lim C, Dillon D, Happ R, Ripepi P, Villella E, Rossi RL, Remine SG, Oster M, Connolly DP, Abrams J, Aljurf A, Hobbs KEF, Li MKW, Howard T, Lee E (1986) Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of patterns of recurrence. Surgery 100: 278-284
18. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, Rougier P, Nordlinger B (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243: 1-7
19. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, DeMatteo RP, D'Angelica M, Blumgart LH, Jarnagin WR (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7: 1034-1044
20. Lorenz M, Staib-Sebler E, Gog C, Proschek D, Jauch KW, Ridwelski K, Hohenberger W, Gassel HJ, Lehmann U, Vestweber KH, Padberg W, Zamzow K, Muller HH (2003) Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralbl Chir 128: 87-94
21. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77: 1254- 1262
22. Nordlinger B, Sorbye H, Debois M, Praet M, Glimelius B, Poston G, Schlag P, Walpole E, Bechstein W, Gruengerger T (2005) Feasibility and risks of pre-operative chemotherapy (CT) with Folfox 4 and surgery for resectable colorectal cancer live metastases (LM). Interim results of the EORTC Intergroup randomised phase III study 40983. J Clin Oncol 23: 3528
23. Parc Y, Dugue L, Farges O, Hiramatsu K, Sauvanet A, Belghiti J (2000) Preoperative systemic 5-fluorouracil does not increase the risk of liver resection. Hepatogastroenterology 47: 1703-1705
24. Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7: 1082- 1088
25. Pocard M, Vincent-Salomon A, Girodet J, Salmon RJ (2001) Effects of preoperative chemotherapy on liver function tests after hepatectomy. Hepatogastroenterology 48: 1406-1408
26. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, Vellone M, Giuliante F, Nuzzo G, Barone C (2004) Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15: 933-939
27. Rees M, Plant G, Bygrave S (1997) Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84: 1136-1140
28. Rees M, Plant G, Wells J, Bygrave S (1996) One hundred fifty hepatic resections: the evolution of technique towards bloodless surgery. Br J Surg 83: 1526-1529
29. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466
30. Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19: 59-71
31. Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77: 1241-1246
32. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343: 1405- 1410
33. Steiner C, Mitzner S (2002) Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry. Liver 22(S2): 20-25
34. Sugarbaker PH (1990) Surgical decision making for large bowel cancer metastatic to the liver. Radiology 174: 621- 626
35. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff P, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 23: 2065-2072